Ratings Surperformance

Trader
Investor
-
Global
-
Quality
ESG MSCI
-

Ratings ESG MSCI

Ratings China Life Insurance Company Limited: Strengths and Weaknesses

Highlights: China Life Insurance Company Limited
  • Its low valuation, with P/E ratio at 5.98 and 8.01 for the ongoing fiscal year and 2026 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
Weaknesses: China Life Insurance Company Limited
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Rating Financials

China Life Insurance Company Limited SectorHong Kong
Fundamentals -
Growth
Revenue growth
EPS growth
FCF growth-
Profitability
EBITDA Margin-
EBIT Margin
Net Margin
Capital Efficiency
ROA
ROCE
ROE
Financial Health-
Gearing
Leverage-
Capital Intensity-
Balance sheet growth
Long Term balance sheet growth
Long term revenue growth
Long term EPS growth
More ratings

Rating Valuation

China Life Insurance Company Limited SectorHong Kong
Global Valuation -
Enterprise value-
EV/Revenue
EV/EBITDA-
EV/FCF-
Equity Valuation
P/E
PBR
Dividend Yield
EV/EBIT
CAPEX/Revenue-
More ratings

Rating Consensus

China Life Insurance Company Limited SectorHong Kong
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (1 year)
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (1 year)
Analysts' target price evolution (4 months)
Analysts' recommendations evolution (7 days)
Target Price evolution (7 days)
More ratings

Rating Business Predictability

China Life Insurance Company Limited SectorHong Kong
Visibility
Analysts' coverage
Financial estimates divergence
Analysts' recommendations divergence
Analysts' Target price divergence
Surprise rates

Rating Revisions

China Life Insurance Company Limited SectorHong Kong
Financial revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
EPS revisions (1 year)
EPS revisions (4 months)
EPS revisions (7 days)
Revenue revisions (7 days)
More ratings

Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
160B - - - -
108B -
AA
- -
59.45B -
41.7B -
AA
- -
29.43B
AA
22.46B -
BBB
- - - -
19.98B
AAA
18.13B -
AA
- -
11.82B -
AAA
- - -
11.2B
BBB
Average 48.16B
AA
Weighted average by Cap.
AA
See all sector ratings
  1. Stock Market
  2. Equities
  3. 2628 Stock
  4. Ratings China Life Insurance Company Limited